Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/6275
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCantilena, S-
dc.contributor.authorPastorino, F-
dc.contributor.authorPezzolo, A-
dc.contributor.authorChayka, O-
dc.contributor.authorPistoia, V-
dc.contributor.authorPonzoni, M-
dc.contributor.authorSala, A-
dc.date.accessioned2012-02-27T09:59:00Z-
dc.date.available2012-02-27T09:59:00Z-
dc.date.issued2011-
dc.identifier.citationOncotarget, 2(12): 976 - 983, Dec 2011en_US
dc.identifier.issn1949-2553-
dc.identifier.urihttp://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=410en
dc.identifier.urihttp://bura.brunel.ac.uk/handle/2438/6275-
dc.descriptionCopyright © 2011 Cantilena et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. The article was made available through the Brunel Open Access Publishing Fund.en_US
dc.description.abstractWnt signalling is an important component of vertebrate development, required for specification of the neural crest. Ten Wnt receptors [Frizzled receptor 1-10 (Fzd1-10)] have been identified so far, some of which are expressed in the developing nervous system and the neural crest. Here we show that expression of one such receptors, Fzd6, predicts poor survival in neuroblastoma patients and marks rare, HIF1/2 α-positive cells in tumour hypoxic areas. Fzd6 positive neuroblastoma cells form neurospheres with high efficiency, are resistant to doxorubicin killing and express high levels of mesenchymal markers such as Twist1 and Notch1. Expression of Fzd6 is required for the expression of genes of the noncanonical Wnt pathway and the spheres forming activity. When transplanted into immunodeficient mice, neuroblastoma cells expressing the Fzd6 marker grow more aggressively than their Fzd6 negative counterparts. We conclude that Fzd6 is a new surface marker of aggressive neuroblastoma cells with stem cell-like features.en_US
dc.description.sponsorshipThis work was sponsored by the Wellcome Trust, the RICC cancer fund, SPARKS, the Italian Association for Cancer Research, Regione Liguria and the Italian Ministry of Health.en_US
dc.languageen-
dc.language.isoenen_US
dc.publisherImpact Journalsen_US
dc.subjectHIFen_US
dc.subjectHypoxiaen_US
dc.subjectMetastasisen_US
dc.subjectNeuroblastomaen_US
dc.subjectStem cellen_US
dc.titleFrizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomasen_US
dc.typeArticleen_US
pubs.organisational-data/Brunel-
pubs.organisational-data/Brunel/Brunel Active Staff-
pubs.organisational-data/Brunel/Brunel Active Staff/School of Health Sciences & Social Care-
pubs.organisational-data/Brunel/Brunel Active Staff/School of Health Sciences & Social Care/Biological Sciences-
pubs.organisational-data/Brunel/University Research Centres and Groups-
pubs.organisational-data/Brunel/University Research Centres and Groups/School of Health Sciences and Social Care - URCs and Groups-
pubs.organisational-data/Brunel/University Research Centres and Groups/School of Health Sciences and Social Care - URCs and Groups/Brunel Institute of Cancer Genetics and Pharmacogenomics-
Appears in Collections:Biological Sciences
Brunel OA Publishing Fund
Cancer
Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
Fulltext.pdf8.04 MBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.